INHA and tuberculosis: Of the 58 individuals who reported a history of prior TB, indicating prior INH use, and had INH-resistant isolates on phenotypic DST, 54 (93.1%) were resistant to INH by LPA, as indicated by 48 (88.9%) having mutations in the katG gene and 6 (11.1%) having mutations in the inhA promoter region.